Publication Name	World Journal of Cardiology
Manuscript ID	20362
Country	Canada

Received	2015-06-03 09:35
Peer-Review Started	2015-06-04 15:27
To Make the First Decision	2015-07-06 14:48
Return for Revision	2015-07-11 16:06
Revised	2015-07-31 22:54
Second Decision	2015-09-10 08:26
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-18 13:30
Articles in Press	2015-09-18 13:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-12 16:30
Publish the Manuscript Online	2015-11-03 08:25

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Review
Article Title	Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?
Manuscript Source	Invited Manuscript
All Author List	Shima Shahbaz, Marcella Manicardi, Giovanni Guaraldi and Paolo Raggi
Funding Agency and Grant Number
Corresponding Author	Paolo Raggi, MD, Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street, Suite 4A7.050, Edmonton T6G 2B7, Alberta, Canada. raggi@ualberta.ca
Key Words	Human immunodeficiency virus infection; Atherosclerosis; Cardiovascular risk; Antiretroviral therapy; Dyslipidemia; Hypertension; Smoking; Cardiovascular death
Core Tip	Infection with the human immunodeficiency virus (HIV) was initially universally lethal but with the introduction of highly active antiretroviral therapies (HAART) the life span of HIV infected patients has drastically increased. Along with the lengthening of life span chronic diseases such as non-acquired immuno?deficiency syndrome related cancers and cardiovascular diseases surfaced. Currently cardiovascular disease is the primary cause of death among HIV infected patients in industrialized countries and its pathogenesis is very complex. A combination of direct virion injury, chronic low-grade inflammation, adverse cardiometabolic effects of HAART and high burden of traditional risk factors contribute to this new epidemic.
Publish Date	2015-11-03 08:25
Citation	Shahbaz S, Manicardi M, Guaraldi G, Raggi P. Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol 2015; 7(10): 633-644
URL	http://www.wjgnet.com/1949-8462/full/v7/i10/633.htm
DOI	http://dx.doi.org/10.4330/wjc.v7.i10.633

Full Article (PDF)	WJC-7-633.pdf
Full Article (Word)	WJC-7-633.doc
Manuscript File	20362-Review.docx
Answering Reviewers	20362-Answering reviewers.pdf
Audio Core Tip	20362-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20362-Conflict-of-interest statement.pdf
Copyright License Agreement	20362-Copyright assignment.pdf
Peer-review Report	20362-Peer-review(s).pdf
Scientific Misconduct Check	20362-Scientific misconduct check.pdf
Scientific Editor Work List	20362-Scientific editor work list.pdf